Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab, and atezolizumab

from Cancer via ola Kala on Inoreader http://ift.tt/2zcvsFb
via IFTTT